CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
86 hedge funds and large institutions have $1.74B invested in China Biologic Products Holdings, Inc. in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
21% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 34
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Holders
86
Holding in Top 10
5
Calls
$12.8M
Puts
$450K
Top Buyers
| 1 | +$67.2M | |
| 2 | +$64.9M | |
| 3 | +$49.4M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$29.8M |
| 5 |
Millennium Management
New York
|
+$27.1M |
Top Sellers
| 1 | -$74M | |
| 2 | -$50.2M | |
| 3 | -$35.7M | |
| 4 |
PAM
PSquared Asset Management
Zurich,
Switzerland
|
-$24.2M |
| 5 |
Two Sigma Investments
New York
|
-$22.2M |
